期刊文献+

氯沙坦对高血压并阵发性心房颤动病人左心房功能影响 被引量:6

EFFECT OF LOSARTAN ON THE LEFT ATRIAL FUNCTION IN THE HYPERTENSIVE WITH PAROXYSMAL ATRIAL FIBRILLATION
下载PDF
导出
摘要 目的通过超声心动图观察氯沙坦对高血压并阵发性心房颤动(房颤)病人左心房功能的影响,探讨房颤预防及治疗的方法。方法将76例高血压并阵发性房颤病人随机分为氯沙坦组(n=38)和非洛地平组(n=38),选择20例健康成年人做对照组,分别在用药前和用药后4、12、24周行超声心动图检查。结果12周后氯沙坦组与治疗前比较及与非洛地平组同期治疗后比较,左心房前后径、左心房上下径、左心房最大容积均减小,心房充盈速度、左心房射血力均明显增加(F=23.83~35.84,q=3.036~18.528,P<0.05、0.01)。氯沙坦组的窦性心律维持率高于非洛地平组(χ2=4.338、4.828,P<0.05)。结论氯沙坦在改善高血压并阵发性房颤病人的左心房功能的同时,能有效维持窦性心律。 Objective To investigate the effect of losartan on left atrial function in the hypertensive with paroxysmal atrial fibrillation (PAF) via ultrasonography. Methods Seventy-six hypertensive patients with PAF were evenly randomized to losartan group and felodipine group. Twenty healthy adults were also included as the control. An echocardiography was done before and at four, 12 and 24 weeks after medication. Results The LAAPD, LASID and LAVmax of the hypertensive patients with PAF were found significantly decreased and the PVA and LAEF increased 12 weeks after the treatment when compared with the data obtained before the treatment (F= 23.83-35.84; q= 3. 036-18. 528;P〈0. 05,0. 01). The maintenance of sinus rhythm in losartan group was greatly higher than that in felodipine group (x^2 =4. 338,4. 828; P〈0.05). Conclusion At the same time of improving hypertension and left atrium function, losartan can effectively maintain sinus rhythm of the patients.
出处 《齐鲁医学杂志》 2009年第4期348-350,共3页 Medical Journal of Qilu
关键词 氯沙坦 高血压 心房颤动 心房功能 超声检查 Losartan Hypertension Atrial fibrillation Atrial function, left Ultrasonography
  • 相关文献

参考文献8

  • 1周晓彬,纪新强,徐莉.PPMS 1.5统计软件的功能及其应用[J].青岛大学医学院学报,2009,45(1):91-93. 被引量:284
  • 2WILLEMS R, SIPIDO K R, HOLEMANS P, et al. Different patterns of angiotensin Ⅱ and atrial natriuretic peptide secre tion in a sheep model of atrial fibrillation[J]. J Cardiovasc Electrophysiol, 2001,12 : 1387-1392.
  • 3GOETTE A, STAACK T, ROCKEN C, et al. Increased expression of extracellular signal-regulated kinase and angiotensin converting enzyme in human atria during atrial fibrillation[J]. JAm Coll Cardiol, 2000,35:1669-1677.
  • 4WRIGHT J W, HARDING J W. Brain angiotensin receptor subtypes AT and their functions[J]. Regul Pegul Pept, 1995,59:269.
  • 5AUSMA J, DISPERSYN G D, DUIMEL H, et al. Changes in ultra structural calcium distribute in goat atria during atrial fibrillation [J]. J Mol Cell Cardiol, 2000,32(3):355-364.
  • 6KUMAGAI K, NAKASHIMA H, URATA H, et aI. Effects of angiotensin Ⅱ type Ⅰ receptor antagonist on electrical and structural remodeling in atrial fibrillation[J]. J Am Coll Car diol, 2003,41(12) :2197.
  • 7勇春明,毛拥军.替米沙坦对高血压病人胰岛素抵抗的影响[J].青岛大学医学院学报,2008,44(5):447-448. 被引量:3
  • 8宁险峰,张文忠,刘松,蔡尚郎.缬沙坦后处理对心肌缺血再灌注损伤的保护作用[J].青岛大学医学院学报,2008,44(6):490-492. 被引量:6

二级参考文献21

  • 1张文忠,陈文一,刘松,蔡尚郎.肾脏缺血后处理对家兔缺血再灌注心肌酶的影响[J].齐鲁医学杂志,2007,22(3):204-205. 被引量:5
  • 2MURRY C E, JENNINGS R B, REIMER K A. Preconditioning with ischemia:a delay of lethal cell in jury in ischemic myocardium[J].Circulation, 1986,74(5) : 1124-1136.
  • 3GOTTLIEB R A, BURLESON K O, KLONER R A, et al. Reperfusion injury induces apoptosis in rabbit cardiomyomycytes[J]. J Clin Invest, 1994,94(4):1621-1628.
  • 4ZHAO Z Q, CORVERA J S, HALKOS M E, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditiong[J]. Am J Physiol, 2003,285 : H579-H588.
  • 5WANG N P, BUNFKIN B L, NAKAMURA M, et al. Ischemic preconditioning reduces neutrophil accumulation and myocardial apoptosis [J].Ann Thorac Surg , 1997 ,67:1685-1695.
  • 6SCHWARTZ L M, LAGRANHA C J. lschemic posteondi tioning during reperfusion activates Akt and ERK without pro tecting against lethal myocardial ischemia reperfusion injury in pigs[J]. Am J Physiol Heart Circ Physiol, 2006,290 (3) : H1011-1018.
  • 7李仲廉.临床疼痛治疗学[M].天津:天津科学技术出版社,1995.245.
  • 8MAGGIO C A, PI-SUNYER F X. The prevention and treatment of obesity: application to type 2 diabetes[J].Diabetes Care, 1997,20:1744-1766.
  • 9李秀钧.代谢综合症(胰岛素抵抗综合症)[M].北京:人民卫生出版社,2007:76-90.
  • 10ADA. Consensus development conference on insulin resistance [J]. Diabetes Care, 1998,21:210.

共引文献290

同被引文献43

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部